RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups

Respiratory Syncytial Virus (RSV) is a common and highly contagious virus that can cause severe illness in vulnerable populations, including older adults with certain underlying health conditions. The expansion of vaccination eligibility to older adults in clinical risk groups aims to provide additional protection against RSV infection, which can lead to serious complications such as bronchiolitis and pneumonia. This move is part of ongoing efforts to mitigate the impact of RSV on high-risk groups and reduce the burden on the healthcare system.

RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups